Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Subcutaneous Sarilumab vs Placebo in Hospitalized Patients With Respiratory Distress Caused by COVID 19

NCT07196306 is registered in ClinicalTrials.gov with BayCare Health System as lead sponsor.

NCT NCT07196306
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07196306 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Subcutaneous Sarilumab vs Placebo in Hospitalized Patients With Respiratory Distress Caused by COVID 19
Lead sponsor
BayCare Health System
Phase
Phase 2
Overall status
Withdrawn
Start date
May 7, 2020
Completion date
October 15, 2020
Enrollment
0 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

corona virus infection, covid, covid-19